Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting.
Marzolini, Maria A V Mehra, Varun Thomson, Kirsty J Tholouli, Eleni Bloor, Adrian J C Parker, Anne Lovell, Richard Orchard, Kim Publicover, Amy Nicholson, Emma
Marzolini, Maria A V
Mehra, Varun
Thomson, Kirsty J
Tholouli, Eleni
Bloor, Adrian J C
Parker, Anne
Lovell, Richard
Orchard, Kim
Publicover, Amy
Nicholson, Emma
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2021-11-09
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available
Citation
Marzolini MAV, Mehra V, Thomson KJ, Tholouli E, Bloor AJC, Parker A, Lovell R, Orchard K, Publicover A, Nicholson E, Snowden JA, Byrne J, Khan A, Gilleece MH, Errico G, Lozano S, Hurst E, Duncan N, Pirrie J, Crea P, Carpenter B, Pagliuca A, Peggs KS. Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting. Blood Adv. 2021 Nov 9;5(21):4500-4503. doi: 10.1182/bloodadvances.2021005637
Type
Article